特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
603536

世界の埋込み型医療機器市場動向、機会分析、市場シェアと予測

Global Implantable Medical Devices Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

出版日: | 発行: Occams Business Research & Consulting Pvt. Ltd. | ページ情報: 英文 190 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.37円
世界の埋込み型医療機器市場動向、機会分析、市場シェアと予測
出版日: 2017年12月23日
発行: Occams Business Research & Consulting Pvt. Ltd.
ページ情報: 英文 190 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の埋込み型医療機器市場について調査し、市場の現状と今後の予測、セグメント別動向、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 市場概要

  • 世界市場:発展と変遷
  • 市場の定義と範囲
  • 業界構造
  • 市場全体分析
  • 予測分析
  • 戦略的分析
  • 競合分析
  • 戦略的提言と主な結論

第3章 市場決定因子

  • 市場促進因子
  • 市場阻害因子
  • 市場の機会
  • 市場の課題

第4章 市場セグメンテーション

  • 製品別
    • 除細動器
    • 心血管インプラント
    • 眼内レンズ
    • 歯科インプラント
    • 豊胸インプラント
    • その他

第5章 競合環境

  • 主な戦略
    • 合併・買収
    • 合弁
    • 製品上市
    • 提携
  • 主要10社

第6章 地域別分析

  • 意思決定サポートデータベースと予測技術
  • 比較分析
  • 機会マトリクス
  • 地域別市場
    • 北米
    • 欧州
    • アジア太平洋地域
    • その他の諸国

第7章 企業プロファイル

目次
Product Code: HME-8721217

Global implantable medical devices market is anticipated to grow with a CAGR of 7.45% in the forecast period 2016-2023. There are numerous factors which help in strengthening implantable medical devices market during forecast period, such as increasing burden of cardiovascular diseases, growing elderly population, rise in prevalence of chronic diseases, increasing healthcare expenditure, rising prevalence of neurological disorders and technological advancements in the field of implantable medical devices. Moreover, huge market opportunities in developing regions, such as APAC and increase in development of minimally invasive & non-surgical procedures are the future opportunity for implantable medical devices market during forecast period 2016-2023. Apart from this, there are several factors which are impacting negatively on the overall implantable medical devices market, such as high cost of treatment associated with implantable medical devices and unfavorable healthcare reforms in U.S.

The global implantable medical devices market is diversified into product. On the basis of product, the market is further diversified into orthopedic implants, cardiovascular implants, intraocular lens implant, dental implants, breast implants and other implants. In which, Orthopedic implants accounted for the largest market share in terms of total share in global implantable medical devices market during forecast period due to increase in osteoporosis-related fractures and cases of obesity.

Based on geography, the global implantable medical devices market is diversified into North America, Europe Asia Pacific and rest of the world. North America implantable medical devices market holds the largest market share due to technological advancement such as, patient-specific implants, especially in knee arthroplasty, using sculptural CAD and 3D technology. U.S. and Canada are some of the major countries of North America which helps to drive the implantable medical devices market in the North America region. In addition to this, Asia Pacific implantable medical devices market is anticipated to grow with highest CAGR in the forecast period 2016-2023. India, China, Japan are some of the major countries of the Asia Pacific region which helps in driving implantable medical devices market in the Asia Pacific region. Due to increasing high incidence of chronic diseases and increase in geriatric population has increased the demand of implantable medical devices market in Asia Pacific region.

Stryker Corporation, Boston Scientific Corporation, Cardinal Health Inc., Johnson & Johnson, Integra Lifesciences Holdings Corporation, Medtronic Plc., Globus Medical Inc., Smith & Nephew Plc., St. Jude Medical Inc., Zimmer Biomet Holdings Inc., and LivaNova Plc., are some of the major companies in the global implantable medical devices market. Acquisition, merger, collaboration, innovation and new product launch are some of the major strategies adopted by the companies.

Table of Contents

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. GLOBAL IMPLANTABLE MEDICAL DEVICES MARKET: EVOLUTION & TRANSITION
  • 2.2. MARKET DEFINITION & SCOPE
  • 2.3. INDUSTRY STRUCTURE
  • 2.4. TOTAL MARKET ANALYSIS
    • 2.4.1. TOP 5 FINDINGS
    • 2.4.2. TOP 5 OPPORTUNITY MARKETS
    • 2.4.3. TOP 5 COMPANIES
    • 2.4.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.5. ESTIMATION ANALYSIS
  • 2.6. STRATEGIC ANALYSIS
    • 2.6.1. INVESTMENT VS. ADOPTION MODEL
    • 2.6.2. 360 DEGREE INDUSTRY ANALYSIS
    • 2.6.3. PORTERS 5 FORCE MODEL
    • 2.6.4. SEE-SAW ANALYSIS
    • 2.6.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
  • 2.7. COMPETITIVE ANALYSIS
    • 2.7.1. KEY STRATEGIES & ANALYSIS
    • 2.7.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
  • 2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.8.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.8.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.8.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. INCREASING BURDEN OF CARDIOVASCULAR DISEASES
    • 3.1.2. GROWING ELDERLY POPULATION
    • 3.1.3. RISE IN PREVALENCE OF CHRONIC DISEASES
    • 3.1.4. INCREASING HEALTHCARE EXPENDITURE
    • 3.1.5. RISING PREVALENCE OF NEUROLOGICAL DISORDERS
    • 3.1.6. TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF IMPLANTABLE MEDICAL DEVICES
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. HIGH COST OF TREATMENT ASSOCIATED WITH IMPLANTABLE MEDICAL DEVICES
    • 3.2.2. UNFAVORABLE HEALTHCARE REFORMS IN THE U.S.
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. HUGE MARKET OPPORTUNITIES IN THE APAC REGION AND DEVELOPING COUNTRIES
    • 3.3.2. INCREASE IN DEVELOPMENT OF MINIMALLY INVASIVE AND NON-SURGICAL PROCEDURES
  • 3.4. MARKET CHALLENGES
    • 3.4.1. DEARTH OF SKILLED PROFESSIONALS
    • 3.4.2. ISSUES RELATED TO THE USE OF IMPLANTABLE MEDICAL DEVICES

4. MARKET SEGMENTATION

  • 4.1. GLOBAL IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION
      • 4.1.5.1. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET
        • 4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.1.4. KEY CONCLUSIONS
      • 4.1.5.2. GLOBAL CARDIOVASCULAR IMPLANTS MARKET
        • 4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.2.4. KEY CONCLUSIONS
      • 4.1.5.3. GLOBAL INTRAOCULAR LENSES MARKET
        • 4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.3.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.3.4. KEY CONCLUSIONS
      • 4.1.5.4. GLOBAL DENTAL IMPLANTS MARKET
        • 4.1.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.4.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.4.4. KEY CONCLUSIONS
      • 4.1.5.5. GLOBAL BREAST IMPLANTS MARKET
        • 4.1.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.5.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.5.4. KEY CONCLUSIONS
      • 4.1.5.6. GLOBAL OTHER MARKET
        • 4.1.5.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.6.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.6.4. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF MERGER & ACQUISITION
    • 5.1.2. LIST OF JOINT VENTURE
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIP
  • 5.2. TOP 10 COMPANY ANALYSIS

6. GEOGRAPHICAL ANALYSIS

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GLOBAL IMPLANTABLE MEDICAL DEVICES MARKET BY REGION 2014-2023 ($ MILLION)
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.3. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.3. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.3. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.3. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.3. KEY CONCLUSIONS
        • 6.4.2.2.4. RUSSIA
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.3. KEY CONCLUSIONS
        • 6.4.2.2.5. REST OF EUROPE
          • 6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.5.3. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.3. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.3. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.3. KEY CONCLUSIONS
        • 6.4.3.2.4. AUSTRALIA
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.3. KEY CONCLUSIONS
        • 6.4.3.2.5. REST OF ASIA PACIFIC
          • 6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.5.3. KEY CONCLUSIONS
    • 6.4.4. ROW
      • 6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.3. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. ABBOTT LABORATORIES
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. STRATEGIC INITIATIVES
    • 7.1.4. SCOT ANALYSIS
    • 7.1.5. STRATEGIC ANALYSIS
  • 7.2. BOSTON SCIENTIFIC CORPORATION
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. STRATEGIC INITIATIVES
    • 7.2.4. SCOT ANALYSIS
    • 7.2.5. STRATEGIC ANALYSIS
  • 7.3. CARDINAL HEALTH INC.
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. STRATEGIC INITIATIVES
    • 7.3.4. SCOT ANAL
    • 7.3.5. STRATEGIC ANALYSIS
  • 7.4. GLOBUS MEDICAL INC.
    • 7.4.1. OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. STRATEGIC INITIATIVES
    • 7.4.4. SCOT ANALYSIS
    • 7.4.5. STRATEGIC ANALYSIS
  • 7.5. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. STRATEGIC INITIATIVES
    • 7.5.4. SCOT ANALYSIS
    • 7.5.5. STRATEGIC ANALYSIS
  • 7.6. JOHNSON & JOHNSON
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. STRATEGIC INITIATIVES
    • 7.6.4. SCOT ANALYSIS
    • 7.6.5. STRATEGIC ANALYSIS
  • 7.7. LIVANOVA PLC
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. STRATEGIC INITIATIVES
    • 7.7.4. SCOT ANALYSIS
    • 7.7.5. STRATEGIC ANALYSIS
  • 7.8. MEDTRONIC PLC
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. STRATEGIC INITIATIVES
    • 7.8.4. SCOT ANALYSIS
    • 7.8.5. STRATEGIC ANALYSIS
  • 7.9. MED-EL
    • 7.9.1. OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. STRATEGIC INITIATIVES
    • 7.9.4. SCOT ANALYSIS
    • 7.9.5. STRATEGIC ANALYSIS
  • 7.10. NUVASIVE INC.
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. STRATEGIC INITIATIVES
    • 7.10.4. SCOT ANALYSIS
    • 7.10.5. STRATEGIC ANALYSIS
  • 7.11. SMITH & NEPHEW PLC
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. STRATEGIC INITIATIVES
    • 7.11.4. SCOT ANALYSIS
    • 7.11.5. STRATEGIC ANALYSIS
  • 7.12. SONOVA HOLDING AG
    • 7.12.1. OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. STRATEGIC INITIATIVES
    • 7.12.4. SCOT ANALYSIS
    • 7.12.5. STRATEGIC ANALYSIS
  • 7.13. STRYKER CORPORATION
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. STRATEGIC INITIATIVES
    • 7.13.4. SCOT ANALYSIS
    • 7.13.5. STRATEGIC ANALYSIS
  • 7.14. WRIGHT MEDICAL GROUP N.V.
    • 7.14.1. OVERVIEW
    • 7.14.2. PRODUCT PORTFOLIO
    • 7.14.3. STRATEGIC INITIATIVES
    • 7.14.4. SCOT ANALYSIS
    • 7.14.5. STRATEGIC ANALYSIS
  • 7.15. ZIMMER BIOMET HOLDINGS INC.
    • 7.15.1. OVERVIEW
    • 7.15.2. PRODUCT PORTFOLIO
    • 7.15.3. STRATEGIC INITIATIVES
    • 7.15.4. SCOT ANALYSIS
    • 7.15.5. STRATEGIC ANALYSIS

LIST OF TABLES

  • 1. GLOBAL IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2014-2023($ MILLION)
  • 2. GLOBAL ORTHOPEDIC IMPLANTS MARKET 2014-2023($ MILLION)
  • 3. GLOBAL CARDIOVASCULAR IMPLANTS MARKET 2014-2023($ MILLION)
  • 4. GLOBAL INTRAOCULAR LENSES MARKET 2014-2023($ MILLION)
  • 5. GLOBAL DENTAL IMPLANTS MARKET 2014-2023($ MILLION)
  • 6. GLOBAL BREAST IMPLANTS MARKET 2014-2023($ MILLION)
  • 7. GLOBAL OTHER IMPLANTS MARKET 2014-2023($ MILLION)
  • 8. NORTH AMERICA IMPLANTABLE MEDICAL DEVICES MARKET 2014-2023 ($ MILLION)
  • 9. EUROPE IMPLANTABLE MEDICAL DEVICES MARKET 2014-2023 ($ MILLION)
  • 10. ASIA PACIFIC IMPLANTABLE MEDICAL DEVICES MARKET 2014-2023 ($ MILLION)
  • 11. REST OF THE WORLD IMPLANTABLE MEDICAL DEVICES MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ORTHOPEDIC IMPLANTS MARKET 2014-2023($ MILLION)
  • 2. GLOBAL CARDIOVASCULAR IMPLANTS MARKET 2014-2023($ MILLION)
  • 3. GLOBAL INTRAOCULAR LENSES MARKET 2014-2023($ MILLION)
  • 4. GLOBAL DENTAL IMPLANTS MARKET 2014-2023($ MILLION)
  • 5. GLOBAL BREAST IMPLANTS MARKET 2014-2023($ MILLION)
  • 6. GLOBAL OTHER IMPLANTS MARKET 2014-2023($ MILLION)
  • 7. UNITED STATES (U.S.) IMPLANTABLE MEDICAL DEVICES MARKET 2014-2023 ($ MILLION)
  • 8. CANADA IMPLANTABLE MEDICAL DEVICES MARKET 2014-2023 ($ MILLION)
  • 9. UNITED KINGDOM (UK) IMPLANTABLE MEDICAL DEVICES MARKET 2014-2023 ($ MILLION)
  • 10. FRANCE IMPLANTABLE MEDICAL DEVICES MARKET 2014-2023 ($ MILLION)
  • 11. GERMANY IMPLANTABLE MEDICAL DEVICES MARKET 2014-2023 ($ MILLION)
  • 12. RUSSIA IMPLANTABLE MEDICAL DEVICES MARKET 2014-2023 ($ MILLION)
  • 13. ROE IMPLANTABLE MEDICAL DEVICES MARKET 2014-2023 ($ MILLION)
  • 14. INDIA IMPLANTABLE MEDICAL DEVICES MARKET 2014-2023 ($ MILLION)
  • 15. CHINA IMPLANTABLE MEDICAL DEVICES MARKET 2014-2023 ($ MILLION)
  • 16. JAPAN IMPLANTABLE MEDICAL DEVICES MARKET 2014-2023 ($ MILLION)
  • 17. AUSTRALIA IMPLANTABLE MEDICAL DEVICES MARKET 2014-2023 ($ MILLION)
  • 18. ROAPAC IMPLANTABLE MEDICAL DEVICES MARKET 2014-2023 ($ MILLION)
  • 19. LATIN AMERICA IMPLANTABLE MEDICAL DEVICES MARKET 2014-2023 ($ MILLION)
  • 20. MENA IMPLANTABLE MEDICAL DEVICES MARKET 2014-2023 ($ MILLION)
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.